Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients (Q77391585)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

systemic lupus erythematosus

1 reference

L Gómez-Pacheco

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A R Villa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

C Drenkard

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

J Cabiedes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

A R Cabral

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

D Alarcón-Segovia

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Medicine

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

106

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

417-423

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Accuracy of Anticardiolipin Antibodies in Identifying a History of Thrombosis Among Patients With Systemic Lupus Erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

The management of thrombosis in the antiphospholipid-antibody syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

The presence of antiphospholipid antibodies in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Recurrent stroke and thrombo-occlusive events in the antiphospholipid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta 2-glycoprotein I (apolipoprotein H)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Antiphospholipid antibodies and the antiphospholipid syndrome. Clinical relevance in neuropsychiatric systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

The 1982 revised criteria for the classification of systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Anticardiolipin antibodies and beta 2-glycoprotein I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Antibodies to beta 2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Antibodies to phospholipid-binding plasma proteins and occurrence of thrombosis in patients with systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

The antiphospholipid/cofactor syndromes: a primary variant with antibodies to beta 2-glycoprotein-I but no antibodies detectable in standard antiphospholipid assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Antiphospholipid antibodies and thrombosis: assessment of the potential risk for thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Activated protein C resistance phenotype and genotype in patients with primary antiphospholipid syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Binding of beta 2-glycoprotein I to platelets: effect of adenylate cyclase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2899%2900053-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(99)00053-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10225244%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference